Activity of Mefloquine Against Urinary Schistosomiasis
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Urinary schistosomiasis is a debilitating disease in Central Africa and pregnant women are
frequently suffering from this condition. Mefloquine is currently investigated as preventive
treatment against malaria in pregnancy and mefloquine is also known to exert activity against
schistosomiasis. The investigators want to test the hypothesis whether mefloquine may active
against urinary schistosomiasis when used as preventive treatment against malaria in
pregnancy.
Phase:
Phase 2
Details
Lead Sponsor:
Albert Schweitzer Hospital
Treatments:
Fanasil, pyrimethamine drug combination Mefloquine